Open AccessMedicineBiology

F. Bifari, V. Lisi, Elda Mimiola, A. Pasini, M. Krampera

2008.5.16TRANSFUSION MEDICINE AND HEMOTHERAPY

DOI: 10.1159/000128968

Résumé tlooto

By choosing MSC tissue origin, cell dose, administration route, and treatment schedule, all the potential side effects related to MSC use, including tumor growth enhancement, have to be well considered to maximize the benefits of MSC-dependent immune regulation without significant risks for the patients.

Résumé

Le résumé n’est pas disponible.

Format de citation

BIFARI, F., et al. Immune modulation by mesenchymal stem cells. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2008, 35: 194–204.